CHICO, Calif.--(BUSINESS WIRE)--PinPointe FootLaser today announced it has received approval from the Therapeutic Goods Administration (TGA) for its new laser treatment for toenail fungus (Onychomycosis), certifying it has met the TGA’s consumer and health safety standards and can be offered by certified health care providers throughout Australia and New Zealand. The treatment, introduced in 2008, has been awarded the CE Mark certifying it has met European Union consumer health and safety standards, has been cleared for use in the treatment of toenail fungus in the EU, and can be offered by healthcare providers throughout Europe. Additionally, it is FDA cleared for applications in dermatology, plastic surgery, and podiatry in the United States.
